Articles

Optimizing Cardiovascular Outcomes in Patients with Type 2 Diabetes—Clinical Implications of the FIELD Results

Citation:

US Cardiology 2006;3(2):47–53

Overview to Antihypertensive and Lipid-lowering Therapies and Patient Care

Citation:

US Cardiology 2006;3(2):18–9

Reducing the Threat of Vascular Disease in Patients with Hypertension and Hyperlipidemia by Addressing Poor Adherence

Citation:

US Cardiology 2006;3(2):22–3

Support for Combined Administration of Antihypertensive and Lipid-lowering Agents to Reduce Cardiovascular Events - The Emergence of the Multipill

Citation:

US Cardiology 2006;3(2):1–3

The Role of Angiotensin Receptor Blockers in Cardiovascular Protection Beyond Blood Pressure Control

Citation:

US Cardiology 2006;3(2):37–9

The Role of Angiotensin Receptor Blockers in Treating Hypertension

Citation:

US Cardiology 2006;3(2):28–31

The Role of Myocardial Perfusion Imaging in the Clinical Evaluation of CAD

Citation:

US Cardiology 2006;3(2):68–72

Treating the Common Dyslipidemia in Patients with Type 2 Diabetes—Insights from FIELD on the Effects of Fenofibrate on CVD Risk

Citation:

US Cardiology 2006;3(1):21–6

Troponin and C-reactive Protein for Risk Stratification

Citation:

US Cardiology 2006;3(2):40–2

Transcatheter Interventional Techniques in Pediatric Cardiology

Citation:

US Cardiology 2005;2(1):157-8